Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.

Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.

Item
http://www.wikidata.org/entity/Q37352842
Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation OncologyThe science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsChanges in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.Local application of ibandronate/gelatin sponge improves osteotomy healing in rabbits.Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate.Prolonged recovery time from zoledronic Acid induced acute tubular necrosis: a case report and review of the literature.Zoledronic acid: an unending tale for an antiresorptive agent.Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors.Effects of zoledronic acid and ibandronic acid on renal functions and calcium, phosphorus and alkaline phosphatase levels in breast cancer patients with bone metastases: a retrospective analysis.Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid.
P2860

Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.

Item
http://www.wikidata.org/entity/Q37352842
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of renal impairment after ...... ective medical records review.
@en
Risk of renal impairment after ...... ective medical records review.
@nl
type
label
Risk of renal impairment after ...... ective medical records review.
@en
Risk of renal impairment after ...... ective medical records review.
@nl
prefLabel
Risk of renal impairment after ...... ective medical records review.
@en
Risk of renal impairment after ...... ective medical records review.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Risk of renal impairment after ...... ective medical records review.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698